Recor Medical Overview
- Founded
- 2009
- Status
- Acquired/Merged
- Employees
- 89
- Latest Deal Type
- M&A
Recor Medical General Information
Description
Developer of a unique therapeutic non-focused ultrasound system designed for the treatment of resistant hypertension and high-blood pressure. The company's therapeutic ultrasound system is designed to decrease the over-activity of nerves leading to the kidneys and the company also designs and manufactures a proprietary ultrasound ablation system by combining the protection of water-based cooling of the renal artery with high intensity ultrasound energy for circumferential renal nerve ablation, enabling patients to decrease the over-activity of the sympathetic nervous system to lower blood pressure.
Contact Information
Website
www.recormedical.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Parent Company
Primary Office
- 1049 Elwell Court
- Palo Alto, CA 94303
- United States
+1 (650) 000-0000
Recor Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 10-Jul-2018 | 000.00 | Completed | Generating Revenue | ||
| 6. Debt - General | 12-Aug-2017 | 0000 | 000.00 | Completed | Generating Revenue | |
| 5. Debt - General | 12-May-2016 | 0000 | 000.00 | Completed | Clinical Trials - General | |
| 4. Later Stage VC (Series D) | 16-Apr-2015 | 0000 | 000.00 | 000.00 | Completed | Startup |
| 3. Later Stage VC (Series C) | 28-Feb-2013 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Early Stage VC (Series B) | 26-Oct-2011 | $10.4M | $12.9M | 000.00 | Completed | Startup |
| 1. Early Stage VC (Series A) | 01-Oct-2009 | $2.5M | $2.5M | 00.00 | Completed | Startup |
Recor Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 14,853,029 | $0.000100 | $0.06 | $0.73 | $0.73 | 1x | $0.73 | 15.03% |
| Series A | 12,499,998 | $0.000100 | $0.02 | $0.2 | $0.2 | 1x | $0.2 | 12.65% |
Recor Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a unique therapeutic non-focused ultrasound system designed for the treatment of resistant hypertension and
Therapeutic Devices
Palo Alto, CA
89
As of 2020
000.00
000000&0
000.00
00000000
esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
00000000000 0000000
Baltimore, MD
00
As of 0000
000
00000000000
000
00000
lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
00000000000 0000000
Redwood City, CA
000
As of 0000
00000
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialRecor Medical Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ReGelTec | Venture Capital-Backed | Baltimore, MD | 00 | 000 | 00000000000 | 000 |
| 00000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Milan, Italy | 00 | 00.000 | 0000000000 | 00.000 |
| 00000000 0000000 | Private Equity-Backed | Charlotte, NC | 0000 | 000000000 - | 0000 | |
| 00000000000 | Venture Capital-Backed | Plymouth, MN | 00 | 00000 | 00000000000 | 00000 |
Recor Medical Patents
Recor Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170027460-A1 | Intraluminal microneurography probe | Abandoned | 29-Jul-2015 | 00000000000 | 0 |
| US-20200077907-A1 | Intraluminal microneurography denervation probe with radio frequency ablation | Pending | 29-Jul-2015 | 00000000000 | |
| US-20170035310-A1 | Intraluminal microneurography denervation probe with radio frequency ablation | Abandoned | 29-Jul-2015 | 00000000000 | 0 |
| US-9999463-B2 | Monitoring nerve activity | Active | 14-Apr-2014 | 00000000000 | 0 |
| US-20150289931-A1 | Monitoring and ablation of autonomic nerves | Granted | 14-Apr-2014 | A61B18/1492 |
Recor Medical Executive Team (11)
Recor Medical Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrew Weiss | Recor Medical | Chief Executive Officer, President & Board Member | 000 0000 |
| Antoine Papiernik | Sofinnova Partners | Board Member | 000 0000 |
| Frank Litvack MD | Self | Board Member | 000 0000 |
| Kazumichi Kobayashi | Otsuka Holdings | Board Member | 000 0000 |
| Mano Iyer | Recor Medical | Co-Founder, Board Member & Chief Operating Officer | 000 0000 |
Recor Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRecor Medical Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Sofinnova Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
